Strota / PPLPHARMA / Quarterly results

Piramal Pharma Q1 FY27 Results: Revenue, Profit and Share Price Reaction

Piramal Pharma's quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹2,270 crore (+17.4% year on year), net profit ₹-69.39 crore, EPS ₹-0.52. Announced 29 Jul 2026, 8:56 pm IST. The shares rose 0.53% on 30 Jul 2026, 0.26 points better than the Nifty 50. Next results board meeting: 27 Oct 2026.
Revenue
₹2,270 cr
YoY +17.4% · QoQ -17.5%
Net profit
₹-69.39 cr
YoY — · QoQ —
EPS (basic)
₹-0.52
YoY —
Share price reaction
+0.5%
30 Jul 2026 · vs Nifty +0.3%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹2,754 cr Q4 FY25 net profit: ₹154 cr Q4 FY25 Q1 FY26 Revenue: ₹1,934 cr Q1 FY26 net profit: ₹-81.70 cr Q1 FY26 Q2 FY26 Revenue: ₹2,044 cr Q2 FY26 net profit: ₹-99.22 cr Q2 FY26 Q3 FY26 Revenue: ₹2,140 cr Q3 FY26 net profit: ₹-136 cr Q3 FY26 Q4 FY26 Revenue: ₹2,752 cr Q4 FY26 net profit: ₹-8.82 cr Q4 FY26 Q1 FY27 Revenue: ₹2,270 cr Q1 FY27 net profit: ₹-69.39 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY2729 Jul 2026, 8:56 pm IST 2,270+17.4%-69.39— -3.1%-0.52 +0.5%
Q4 FY2628 Apr 2026, 9:42 pm IST 2,752-0.1%-8.82-105.7% -0.3%-0.07 -2.6%
Q3 FY2629 Jan 2026, 12:12 pm IST 2,140—-136— -6.4%-1.03 -0.2%
Q2 FY265 Nov 2025, 9:00 pm IST 2,044—-99.22— -4.9%-0.75 -0.5%
Q1 FY2628 Jul 2025, 9:53 pm IST 1,934—-81.70— -4.2%-0.62 +0.6%
Q4 FY2514 May 2025, 9:47 pm IST 2,754—154— 5.6%1.16 -4.8%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How PPLPHARMA shares react to results

Across the last 6 results here, the shares rose on 2 and fell on 4. The average move was -1.16%, and the average size of the move either way 1.54%; the biggest was -4.76% after the Q4 FY25 results.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were Piramal Pharma's Q1 FY27 results?

For the quarter to 30 Jun 2026, Piramal Pharma reported revenue of ₹2,270 crore (+17.4% year on year) and net profit of ₹-69 crore, with basic EPS of ₹-0.52.

How did Piramal Pharma shares react to the Q1 results?

They rose 0.53% on 30 Jul 2026, the first session that could trade on the results (announced after the close); that was 0.26 points better than the Nifty 50 that day.

When is Piramal Pharma's next results date?

The board meets on 27 Oct 2026 to consider results, according to the company's intimation to NSE.

Do Piramal Pharma shares usually rise after results?

In the last 6 results here they rose 2 times and fell 4 times, moving 1.54% on average either way.

About this data

From Piramal Pharma's Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See PPLPHARMA stock page for price, open interest and deals, all results declared this week and the results calendar, and PPLPHARMA dividend history.